Le Lézard
Classified in: Health
Subject: SVY

Surgical Sealants and Adhesives Market Expected to Reach $3,794 Million by 2023 - Allied Market Research


PORTLAND, Oregon and PUNE, India, March 21, 2018 /PRNewswire/ --

According to a new report published by Allied Market Research, titled, Surgical sealants and adhesives Market by Product, Indication, Application, and Geography: Global Opportunity Analysis and Industry Forecast, 2017-2023," the global surgical sealants and adhesives market accounted for $1,993 million in 2016, and is expected to reach $3,794 million by 2023 with a CAGR of 9.7% from 2017 to 2023. North America is the highest contributor in the surgical sealants and adhesives market in 2016; however, Asia-Pacific is expected to witness the highest growth rate during the forecast period.

     (Logo: https://mma.prnewswire.com/media/636519/Allied_Market_Research_Logo.jpg )

Adhesives and sealants are used during surgical procedures to reinforce surgical wounds, repair injured tissues, or even replace common suturing techniques. These products can be used as adjuncts to sutures to prevent air and liquid leakages. They can be developed naturally or synthetically, and are used generate three-dimensional networks, which bind to the target tissues and act as sealants, hemostats, or adhesives.

Request Sample Report at: https://www.alliedmarketresearch.com/request-sample/1050

The major driving factors of surgical sealants and adhesives market are rise in geriatric population, surge in prevalence of chronic diseases, and increase in awareness towards the benefits of using surgical sealants and adhesives. Furthermore, increase in number of surgical procedures globally and adoption of technologically advanced products fuel the growth of this market. However, rise in popularity of minimally invasive surgeries, high cost of these sealants and adhesive agents, and requirement of large amount of clinical data for the launch of new products are expected to hamper the market growth.

Among the product segment, natural sealants and adhesives dominates the market, as these products cause less immunogenic reaction, are available abundantly, and are thus less expensive as compared to synthetic products. However, the synthetic and semisynthetic sealants and adhesives segment registers the highest growth rate, as these products are more durable and flexible in nature.

Among the indication segment, tissue engineering is anticipated to grow at the highest rate, owing to upsurge in demand for tissue regeneration products in case of traumatic & burn injuries and rise in number of cosmetic surgeries.

For Purchase Enquiry: https://www.alliedmarketresearch.com/purchase-enquiry/1050

Key Findings of the Surgical Sealants and Adhesives Market: 


In 2016, North America was the dominant revenue contributor, owing to high prevalence of chronic diseases, increase in disposable income, and surge in number of surgical procedures. However, Asia-Pacific is witnessing the highest CAGR during the analysis period, owing to the presence of high populace countries such as India and China, which in turn increases the prevalence rate of chronic diseases, geriatric population, and the number of cosmetic surgeries being conducted.

The key players operating in the global surgical sealants and adhesives market include Baxter International Inc., B. Braun Melsungen AG, Cohera Medical, Inc., CryoLife Inc., C.R. Bard Inc., CSL Limited (CSL Behring), Johnson & Johnson (Ethicon, Inc.), Ocular Therapeutix Inc., Sanofi, and Sealantis Ltd.

Other prominent players in the value chain include Vivostat A/S, Medtronic plc, Mallinckrodt plc, Cardinal Health, Integra LifeSciences Holdings Corporation, and LifeBond Ltd.

Access KNOWLEDGE TREE (Premium on-demand, subscription-based pricing model) at: https://www.alliedmarketresearch.com/knowledgetree

Knowledge tree is a cloud-based intelligence platform that offers more than 2,000 selective, off-the-shelf reports on niche markets to enable our clients gain deep insights on the latest trends, dynamic technologies, and emerging application areas. 

About Us 

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.


Contact:
Shriram Dighe
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1?855?550-5975
[email protected]

Web: https://www.alliedmarketresearch.com



These press releases may also interest you

at 04:00
Bioforum, the Data Masters, a leading contract research organization (CRO) focused on the delivery of biometric services and solutions to the global clinical trials industry, today announced the launch of SUBMIT24 in its beta version during Q3 2024,...

at 04:00
TVM Capital Healthcare, a specialist healthcare private equity firm headquartered in Dubai and...

at 03:26
Calliditas Therapeutics AB , ("Calliditas") today announced that the global open-label extension (OLE) study to the Phase 3 NefIgArd study showed a treatment response consistent with the NefIgArd study across endpoints of urine protein to creatinine...

at 03:00
Flindr...

at 03:00
CSL Vifor and Travere Therapeutics, Inc., today announced that the European Commission has granted conditional marketing authorization (CMA) for FILSPARI (sparsentan) for the...

at 03:00
Tetra Pharm Technologies and Glysious are pleased to announce a strategic collaboration aimed at developing a ground-breaking transdermal drug delivery system complementing several of Tetra Pharm Technologies' pipeline candidates. The...



News published on and distributed by: